Available Trials

Breast Cancer

  • USO 11025 (STAR TRIAL)

    A Phase II Multicenter Single-arm Study of BKM120 plus Capecitabine for Breast Cancer Patients with Brain Metastasis.

    Available at 6 locations

  • USO 15130

    A Phase 2 Open Label, Multi-Center, Multinational Study Investigating The Efficacy and Safety Of GTx-024 On Advanced, Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)

    Available at 6 locations

  • USO 13033

    A Phase II, Multicenter, Randomized, Parallel Group Study to Compare Alisertib in Combination with Paclitaxel vs. Paclitaxel Alone in Patients with Metastatic or Locally Recurrent Breast Cancer with histologic confirmation: ER+, HER2- invasive breast cancer (any PgR status) or poorly differentiated and/or invasive TNBC as defined by HER2-, ER-/PR- status, with Measurable disease by RECIST 1.1, or non measurable lytic, bone-only disease. Cannot have more than 1 chemo in metastatic setting.

    Available at 6 locations